XNYS
SLGN
Market cap4.65bUSD
Jul 09, Last price
44.01USD
1D
0.00%
1Q
6.10%
Jan 2017
71.98%
Name
Silgan Holdings Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Silgan Holdings Inc., along with its affiliates, manufactures and distributes rigid packaging solutions for consumer products across North America, Europe, and other global markets. The company operates through three principal divisions. Its Metal Containers segment produces steel and aluminum cans for a wide variety of food items, such as pet food, vegetables, soups, proteins, tomato-based products, adult nutritional beverages, and fruits, in addition to general-purpose metal containers primarily for chemicals. The Dispensing and Specialty Closures segment offers an extensive selection of metal and plastic closures and advanced dispensing systems, which find application in food, beverage, healthcare, garden, home, personal care, and beauty products, as well as providing capping/sealing machinery and detection systems. Furthermore, the Custom Containers segment specializes in creating bespoke and standard plastic containers for industries including personal care, healthcare, food and beverage, household and industrial chemicals, pharmaceuticals, pet food and care, agriculture, automotive, and marine chemicals. This segment also fabricates plastic thermoformed barrier and non-barrier bowls and trays for prepared meals and pet food, along with various plastic closures, caps, sifters, fitments, and thermoformed tubs designed for food, household, and personal care products, like soft fabric wipes. Silgan markets its offerings predominantly via its dedicated sales team, complemented by a network of distributors and an online catalog. Established in 1987, the company's main office is located in Stamford, Connecticut.
IPO date
Feb 14, 1997
Employees
15,425
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||